Cargando…

A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children

Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Jeffrey S., Hirankarn, Sarapee, Holford, Nick, Hammer, Gregory B., Drover, David R., Cohane, Carol A., Anderson, Brian, Dombrowski, Erin, Reece, Tammy, Zajicek, Anne, Schulman, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516882/
https://www.ncbi.nlm.nih.gov/pubmed/26283961
http://dx.doi.org/10.3389/fphar.2015.00151
_version_ 1782383113657122816
author Barrett, Jeffrey S.
Hirankarn, Sarapee
Holford, Nick
Hammer, Gregory B.
Drover, David R.
Cohane, Carol A.
Anderson, Brian
Dombrowski, Erin
Reece, Tammy
Zajicek, Anne
Schulman, Scott R.
author_facet Barrett, Jeffrey S.
Hirankarn, Sarapee
Holford, Nick
Hammer, Gregory B.
Drover, David R.
Cohane, Carol A.
Anderson, Brian
Dombrowski, Erin
Reece, Tammy
Zajicek, Anne
Schulman, Scott R.
author_sort Barrett, Jeffrey S.
collection PubMed
description Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size dependencies; and determine vulnerable populations or patient subtypes that may elicit dosing modifications. A multi-center, randomized, double-blinded, parallel-group, dose-ranging, effect-controlled study, followed by an open-label dose titration of an intravenous infusion of SNP was undertaken in 203 pediatric subjects, who required deliberate hypotension or controlled normotension during anesthesia. A total of 3464 MAP measurements collected from 202 patients during the study's blinded phase, including baseline measurements up to 6 min prior to the blinded were available for analysis. A population K-PD model was developed with a one-compartment model assumed for SNP. Size differences in CL and V of the effect compartment were described using theory-based allometry. An inhibitory sigmoidal E(max) model was used to describe the effect of SNP. A power function of age was used to describe age-related differences in baseline MAP. A mixture model of two groups with low and high EC50 was used to explain variability in MAP response. Change in MAP was characterized by a linear disease progression slope during the blinded phase. In the final population model, CL and V increased with weight, and baseline MAP increased with age. The effect compartment half-life of SNP was 13.4 min. The infusion rate producing 50% of E(max) (ER50) at steady state for high EC50, was 0.34 μg/kg/min and for low EC50 0.103 μg/kg/min. The K-PD model well-describes initial dosing of SNP under controlled circumstances; model-based dosing guidance agrees with current practice. An initial titration strategy supported via algorithm-based feedback should improve maintenance of target MAP.
format Online
Article
Text
id pubmed-4516882
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45168822015-08-17 A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children Barrett, Jeffrey S. Hirankarn, Sarapee Holford, Nick Hammer, Gregory B. Drover, David R. Cohane, Carol A. Anderson, Brian Dombrowski, Erin Reece, Tammy Zajicek, Anne Schulman, Scott R. Front Pharmacol Pharmacology Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size dependencies; and determine vulnerable populations or patient subtypes that may elicit dosing modifications. A multi-center, randomized, double-blinded, parallel-group, dose-ranging, effect-controlled study, followed by an open-label dose titration of an intravenous infusion of SNP was undertaken in 203 pediatric subjects, who required deliberate hypotension or controlled normotension during anesthesia. A total of 3464 MAP measurements collected from 202 patients during the study's blinded phase, including baseline measurements up to 6 min prior to the blinded were available for analysis. A population K-PD model was developed with a one-compartment model assumed for SNP. Size differences in CL and V of the effect compartment were described using theory-based allometry. An inhibitory sigmoidal E(max) model was used to describe the effect of SNP. A power function of age was used to describe age-related differences in baseline MAP. A mixture model of two groups with low and high EC50 was used to explain variability in MAP response. Change in MAP was characterized by a linear disease progression slope during the blinded phase. In the final population model, CL and V increased with weight, and baseline MAP increased with age. The effect compartment half-life of SNP was 13.4 min. The infusion rate producing 50% of E(max) (ER50) at steady state for high EC50, was 0.34 μg/kg/min and for low EC50 0.103 μg/kg/min. The K-PD model well-describes initial dosing of SNP under controlled circumstances; model-based dosing guidance agrees with current practice. An initial titration strategy supported via algorithm-based feedback should improve maintenance of target MAP. Frontiers Media S.A. 2015-07-28 /pmc/articles/PMC4516882/ /pubmed/26283961 http://dx.doi.org/10.3389/fphar.2015.00151 Text en Copyright © 2015 Barrett, Hirankarn, Holford, Hammer, Drover, Cohane, Anderson, Dombrowsky, Reece, Zajicek and Schulman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Barrett, Jeffrey S.
Hirankarn, Sarapee
Holford, Nick
Hammer, Gregory B.
Drover, David R.
Cohane, Carol A.
Anderson, Brian
Dombrowski, Erin
Reece, Tammy
Zajicek, Anne
Schulman, Scott R.
A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title_full A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title_fullStr A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title_full_unstemmed A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title_short A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
title_sort hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516882/
https://www.ncbi.nlm.nih.gov/pubmed/26283961
http://dx.doi.org/10.3389/fphar.2015.00151
work_keys_str_mv AT barrettjeffreys ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT hirankarnsarapee ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT holfordnick ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT hammergregoryb ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT droverdavidr ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT cohanecarola ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT andersonbrian ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT dombrowskierin ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT reecetammy ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT zajicekanne ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT schulmanscottr ahemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT barrettjeffreys hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT hirankarnsarapee hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT holfordnick hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT hammergregoryb hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT droverdavidr hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT cohanecarola hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT andersonbrian hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT dombrowskierin hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT reecetammy hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT zajicekanne hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren
AT schulmanscottr hemodynamicmodeltoguidebloodpressurecontrolduringdeliberatehypotensionwithsodiumnitroprussideinchildren